Loading viewer...
investor_presentation
Format: PDF investor_presentation
8-K FURNISHED OCTOBER 24, 2018 THIRD QUARTER 2018 SUPPLEMENTAL FINANCIAL INFORMATION
8-K FURNISHED OCTOBER 24, 2018 THIRD QUARTER 2018
SUPPLEMENTAL FINANCIAL INFORMATION
FORWARD LOOKING STATEMENT
This presentation contains forward -looking statements including but not limited to statements with
respect to estimated 2018 guidance and the related assumptions, the impact of various factors on
operating and financial results, expected savings and synergies (including from the LaunchPad
initiative and as a result of acquisitions), and the opportunities for future growth.
This presentation contains forward -looking statements which are subject to change based on various
important factors, including without limitation, competitive actions and other unforeseen changes and
general uncertainties in the marketplace, changes in government regulations, including health care
reform, customer purchasing decisions, including changes in payer regulations or policies, other
adverse actions of governmental and third -party payers, changes in testing guidelines or
recommendations, adverse results in material litigation matters, the impact of changes in tax laws and
regulations, failure to maintain or develop customer relationships, our ability to develop or acquire
new products and adapt to technological changes, failures in information technology systems or data
security, adverse weather conditions, challenges in implementing business process changes,
employee relations, and the effect of exchange rate fluctuations on international operations.
Actual results could differ materially from those suggested by these forward -looking statements .
Laboratory Corporation of America Holdings (the “Company ”) has no obligation to provide any
updates to these forward -looking statements even if its expectations change. Further information on
potential factors, risks and uncertainties that could affect the operating and financial results of the
Company is included in the Company’s Form 10 -K for the year ended December 31, 2017, and
subsequent Forms 10 -Q, including in each case under the heading risk factors, and in the Company’s
other filings with the SEC. The information in this presentation should be read in conjunction with a
review of the Company’s filings with the SEC including information in the Company’s Form 10 -K for
the year ended December 31, 2017, and subsequent Forms 10 -Q, under the heading MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS. 2
USE OF ADJUSTED MEASURES AND ADOPTION OF ASC 606
The Company has provided in this presentation “adjusted” financial information that has
not been prepared in accordance with GAAP, including Adjusted EPS, Adjusted Operating
Preview truncated — download the full document for the complete content.
conference
29 Pages
PT Chandra Asri Petrochemical Tbk
Münchener Rückversicherungs-Gesellschaft Investor Presentation — February 2020
investor_presentationinvestor_presentation
37 Pages
Münchener Rückversicherungs-Gesellschaft
investor_presentation
PlayAGS